BOULDER, Colo., April 24 /PRNewswire-FirstCall/ -- Pharmion Corporation announced today that Patrick J. Mahaffy, the Company’s president and chief executive officer, will present a corporate overview at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, Florida.
The presentation will take place at 3:00 p.m. (Eastern) on Wednesday, May 2, 2007, at the Ritz-Carlton, Key Biscayne.
There will be a live webcast of the presentation from the conference. The webcast will be accessible through a link posted on the investor relations section of the Pharmion website at http://investor.pharmion.com. The webcast will be available for replay on Pharmion’s website until July 24, 2007. The presentation will also be available to download as a podcast.
About Pharmion
Pharmion is a pharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world’s first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company’s website at www.pharmion.com.
Pharmion Corporation
CONTACT: Breanna Burkart or Anna Sussman, Directors, Investor Relationsand Corporate Communications of Pharmion Corporation, +1-720-564-9150
Web site: http://investor.pharmion.com/
